Onconetix Inc (ONCO) Actualités

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 424B4 - Prospectus [Rule 424(b)(4)]

Form EFFECT - Notice of Effectiveness

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

Form DEF 14C - Other definitive information statements

Form 8-K - Current report

Form PRE 14C - Other preliminary information statements

Form D - Notice of Exempt Offering of Securities

Form 8-K/A - Current report: [Amend]

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

CINCINATTI, OH., Oct. 03, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today...

Form 8-K - Current report